Don’t miss the latest developments in business and finance.

Claris Lifesciences receives EIR from the USFDA

Image
Capital Market
Last Updated : May 30 2016 | 1:01 PM IST

For its manufacturing facility located near Ahmedabad

Claris Lifesciences announced today that it has received the Establishment Inspection Report for its manufacturing facility located near Ahmedabad, wherein the US FDA has concluded that the inspection stands closed and the facility was found to be acceptable.

Powered by Capital Market - Live News

More From This Section

First Published: May 30 2016 | 12:28 PM IST

Next Story